We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300750:SZSEContemporary Amperex Technology Co., Limited Class A Analysis

Data as of 2026-06-20 - not real-time

CN¥391.55

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading below both the short‑term and intermediate moving averages, with the 20‑day SMA under the 50‑day SMA and both beneath the 200‑day SMA, suggesting a neutral to slightly bearish bias. The RSI sits near the mid‑point, while the MACD line remains below its signal line and the histogram is negative, reinforcing short‑term downside pressure. Volume has been trending downwards, and price is holding just above a clear support zone while facing a substantial resistance ceiling. Volatility over the past month is elevated, yet the beta is modest, indicating limited systematic risk.
Fundamental backdrop: Revenue is expanding at a rapid pace, margins are solid and return on equity is high, supported by abundant cash and a manageable debt profile. Valuation metrics show the price‑to‑earnings multiple well below the industry average and a discounted cash‑flow estimate that places fair value far above the current market price, implying a sizable upside potential. The dividend yield is modest but the payout ratio is comfortably low, pointing to sustainable dividend policy. Analyst consensus is strongly positive, reinforcing the growth narrative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price below key moving averages
  • bearish MACD momentum
  • decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • significant DCF upside
  • strong revenue growth and profitability
  • sustainable dividend with low payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • structural demand for EV batteries
  • robust cash generation and low leverage
  • undervaluation relative to peers and growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth52.40%
Profit Margin16.87%
P/E Ratio22.3
ROE25.36%
Debt/Equity32.08
P/B Ratio5.0
Op. Cash FlowCN¥134.0B
Industry P/E31.4

Technical Analysis

TrendNeutral
RSI41.8
SupportCN¥380.03
ResistanceCN¥438.24
MA 20CN¥405.64
MA 50CN¥419.96
MA 200CN¥379.79
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair ValueCN¥792.05
Target PriceCN¥558.06
Upside/Downside42.53%
GradeUndervalued
TypeGrowth
Dividend Yield1.42%

Risk Assessment

Beta0.48
Volatility31.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.